Performance Testing for Dry Powder Inhaler Products: Towards Clinical Relevance
It is well established that the critical performance metrics for aerosol products are aerodynamic particle size distribution (APSD) and delivered dose uniformity (DDU). In broad terms, these performance characteristics dictate the efficiency and reproducibility with which an aerosol is administered...
Main Authors: | Sara E. Maloney, Jeffrey B. Mecham, Anthony J. Hickey |
---|---|
Format: | Article |
Language: | English |
Published: |
Hosokawa Powder Technology Foundation
2022-09-01
|
Series: | KONA Powder and Particle Journal |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/kona/40/0/40_2023013/_html/-char/en |
Similar Items
-
In vitro Evaluation of Dry Powder Inhaler Devices of Corticosteroid Preparations
by: Gen Tamura, et al.
Published: (2012-01-01) -
Impact of selected construction elements of capsule-based dry powder inhalers on the manner of drug delivery to the lungs
by: Marcin Odziomek, et al.
Published: (2016-12-01) -
A Comparison of Aerosol Performance Using Standardized Entrainment Tubes vs. Dry Powder Inhaler Devices
by: Zhen Xu, et al.
Published: (2013-12-01) -
Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development
by: Abhinav Ram Mohan, et al.
Published: (2022-11-01) -
Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
by: Zitong Shao, et al.
Published: (2021-11-01)